Complications from induction regimens for thoracic malignancies. Perioperative considerations.
The treatment of locoregionally advanced non-small cell lung cancer is evolving rapidly, and we as surgeons should continue to take a prominent role, from the pretreatment evaluation phase, through reassessment after induction therapy and intraoperative decision making, to vigilant postoperative care. These are by far the most challenging thoracic oncologic patients to care for. The multidisciplinary team formula required for optimal results and mandates the leadership that we, as surgeons familiar with all facets of patient care, can provide.